Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the transaction, the president now directly owns 1,576,097 shares of the company’s stock, valued at approximately $21,624,050.84. This trade represents a 1.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $14.37 on Friday. The company has a market capitalization of $2.75 billion, a price-to-earnings ratio of -18.66 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company has a 50-day simple moving average of $13.16 and a 200 day simple moving average of $11.73. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.82.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ALHC. Barclays lifted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Stephens reissued an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. Finally, UBS Group lifted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $11.88.

Institutional Trading of Alignment Healthcare

Institutional investors have recently bought and sold shares of the business. R Squared Ltd bought a new stake in Alignment Healthcare in the 4th quarter valued at about $55,000. RiverPark Advisors LLC bought a new stake in Alignment Healthcare in the 4th quarter valued at about $106,000. Tower Research Capital LLC TRC boosted its holdings in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after purchasing an additional 6,286 shares during the period. Ballentine Partners LLC bought a new stake in Alignment Healthcare in the 4th quarter valued at about $121,000. Finally, Aigen Investment Management LP bought a new stake in Alignment Healthcare in the 4th quarter valued at about $129,000. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.